 |
|
|
| |
Glasgow: First Prospective Comparison of Genotypic vs Phenotypic Tropism Assays in Predicting Virologic Responses to Maraviroc (MVC) in a Phase 3 Study: MODERN
|
| |
| |
Reported by Jules Levin
HIV Drug Therapy Glasgow; November 2-6, 2014; Glasgow, UK
J Heera,1SR Valluri,2C Craig,3A Fang,2N Thomas,1RD Meyer,1J Demarest4
1Pfizer Inc, Groton, CT, USA; 2Pfizer Inc, New York, NY, USA; 3Pfizer Inc, Sandwich, Kent, UK; 4ViiV Healthcare, Research Triangle Park, NC, USA
|
| |
|
|
|
|
|
